Delivery Order SPE2DP23D0004-SPE2DP24F2346

Award Date 2/7/24

Potential Completion Date 6/5/24

Potential Value $3.2M

Federal Agency

Medical Supply Chain

Awardee

Valneva Usa, Inc. NT38AFWQNKM7

Ultimate Awardee

Not listed

NAICS Category

325414 - Biological Product (except Diagnostic) Manufacturing

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Full and Open Competition

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Bethesda, MD 20814, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Not listed

Legislative Mandate

Walsh Healy Act

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract (SPE2DP23D0004) to Valneva USA, Inc., doing business as Intercell USA Inc., for the supply of the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $3,203,200.00 and a completion date of June 5, 2024. This order is part of a larger $48,025,600 indefinite-delivery/indefinite-quantity (IDIQ) contract awarded to Valneva USA in 2023, which supports the Department of Defense's medical countermeasures program. Valneva USA is a foreign-owned, for-profit organization that specializes in developing, manufacturing, and delivering vaccines to address infectious diseases for various federal agencies. The contract does not have a set-aside designation, and Valneva USA is the prime contractor.

Generated 7/15/24, 6:49 PM